MyAverix Finance
US · Healthcare
TRACON Pharmaceuticals Inc (TCON)
Biotechnology
TRACON Pharmaceuticals Inc (TCON) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $109,725, P/E ratio is 0.01, net margin is 162.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TCON
TRACON Pharmaceuticals Inc (TCON) — FAQ
What is TRACON Pharmaceuticals Inc's market cap?
TRACON Pharmaceuticals Inc (TCON) has a reported market cap of $109,725 (data as of 2026-03-30).
What is TCON's P/E ratio?
The price-to-earnings (P/E) ratio for TRACON Pharmaceuticals Inc (TCON) is 0.01 (data as of 2026-03-30).
Does TRACON Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for TRACON Pharmaceuticals Inc (TCON). Check the MyAverix Finance app for the latest dividend data.
What sector is TRACON Pharmaceuticals Inc in?
TRACON Pharmaceuticals Inc (TCON) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TCON listed on?
TCON is listed on US.
What is TRACON Pharmaceuticals Inc's net margin?
TRACON Pharmaceuticals Inc (TCON) reports a net margin of 162.3% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.